Article
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.
Nature communications - 20 Nov 2019
van Dessel Lisanne F, van Riet Job, Smits Minke, Zhu Yanyun, Hamberg Paul, van der Heijden Michiel S, Bergman Andries M, van Oort Inge M, de Wit Ronald, Voest Emile E, Steeghs Neeltje, Yamaguchi Takafumi N, Livingstone Julie, Boutros Paul C, Martens John W M, Sleijfer Stefan, Cuppen Edwin, Zwart Wilbert, van de Werken Harmen J G, Mehra Niven, Lolkema Martijn P
Abstract excerpt
Metastatic castration-resistant prostate cancer (mCRPC) has a highly complex genomic landscape. With the recent development of novel treatments, accurate stratification strategies are needed. Here we present the whole-genome sequencing (WGS) analysis of fresh-frozen metastatic biopsies from 197 mCRPC patients. Using unsupervised clustering based on genomic features, we define eight distinct genomic clusters. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
